An innovative 'safety switch' for CAR T-cell therapy, designed at the Malaghan Institute and recently patented, has the potential to significantly enhance the safety and accessibility of this cutting-edge cancer immunotherapy and
https://twtr.to/g9f7e
https://ibit.ly/re5p6
https://twtr.to/Ln2Qb
https://twtr.to/AW0fD
https://ibit.ly/9dHXR
https://twtr.to/fBiLv